NYSE:IMUC

Immunocellular Therapeutics Stock Insider Trading

etoro logo Buy IMUC
*Your capital is at risk
$0.132
-0.103 (-43.98%)
At Close: Jul 31, 2026

ImmunoCellular Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 7.12M and sold 56.57K IMUC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 7.12M shares
Sell 56.57K shares
94% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Sep 18, 2015
Buy
Common Stock
J-Other
Schlossberg Mark A
Director 0
Value: $0
Sep 18, 2015
Buy
Common Stock
A-Award
Singhvi Rahul
Director
Director 10 000
Value: $0
Sep 18, 2015
Buy
Common Stock
A-Award
Singhvi Rahul
Director
Director 10 000
Value: $0
Sep 18, 2015
Buy
Stock Option (Rt to Buy)
A-Award
Schlossberg Mark A
Director
Director 40 000
Value: $18.8K
Sep 18, 2015
Buy
Common Stock
A-Award
Titus Gary
Director
Director 10 000
Value: $0
Sep 18, 2015
Buy
Common Stock
A-Award
Titus Gary
Director
Director 10 000
Value: $0
Sep 18, 2015
Buy
Common Stock
J-Other
Lapointe Anthony Gregg
Director 0
Value: $0
Sep 18, 2015
Buy
Stock Option (Rt to Buy)
A-Award
Lapointe Anthony Gregg
Director
Director 40 000
Value: $18.8K
Jun 26, 2015
Buy
Stock Option (right to buy)
A-Award
Yu John S
Secretary
Officer 50 000
Value: $24.0K
Jun 26, 2015
Buy
Stock Option (right to buy)
A-Award
Titus Gary
Director
Director 75 000
Value: $36.0K
Jun 26, 2015
Buy
Stock Option (right to buy)
A-Award
Singhvi Rahul
Director
Director 70 000
Value: $33.6K
Jun 26, 2015
Buy
Stock Option (right to buy)
A-Award
Singhvi Rahul
Director
Director 70 000
Value: $33.6K
Jun 26, 2015
Buy
Stock Option (right to buy)
A-Award
Titus Gary
Director
Director 75 000
Value: $36.0K
Jun 26, 2015
Buy
Stock Option (right to buy)
A-Award
Yu John S
Secretary
Officer 50 000
Value: $24.0K
Mar 20, 2015
Buy
Stock Option (Rt to Buy)
A-Award
Gengos Andrew
President And CEO
CEO / President 175 000
Value: $99.8K
Mar 20, 2015
Buy
Stock Option (Rt to Buy)
A-Award
Fractor David
See Remarks
Officer 50 000
Value: $28.5K
Mar 20, 2015
Buy
Stock Option (Rt to Buy)
A-Award
Gengos Andrew
President And CEO
CEO / President 175 000
Value: $99.8K
Mar 20, 2015
Buy
Stock Option (Rt to Buy)
A-Award
Gringeri Anthony
Sr. Vp, Strategic Resources
Officer 112 500
Value: $64.1K
Mar 20, 2015
Buy
Common Stock
A-Award
Gringeri Anthony
Sr. Vp, Strategic Resources
Officer 75 000
Value: $0
Mar 20, 2015
Buy
Stock Option (Rt to Buy)
A-Award
Yu John S
See Remarks
Officer 100 000
Value: $57.0K
Mar 20, 2015
Buy
Common Stock
A-Award
Fractor David
See Remarks
Officer 35 000
Value: $0
Mar 20, 2015
Buy
Common Stock
A-Award
Gengos Andrew
President And CEO
CEO / President 150 000
Value: $0
Mar 20, 2015
Buy
Stock Option (Rt to Buy)
A-Award
Fractor David
See Remarks
Officer 50 000
Value: $28.5K
Mar 20, 2015
Buy
Common Stock
A-Award
Fractor David
See Remarks
Officer 35 000
Value: $0
Mar 20, 2015
Buy
Common Stock
A-Award
Gengos Andrew
President And CEO
CEO / President 150 000
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT IMMUNOCELLULAR THERAPEUTICS LTD
ImmunoCellular Therapeutics
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also dev...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE